Baker Bros. Advisors LP Celcuity Inc. Transaction History
Baker Bros. Advisors LP
- $7.9 Billion
- Q1 2024
A detailed history of Baker Bros. Advisors LP transactions in Celcuity Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 1,552,478 shares of CELC stock, worth $24.5 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
1,552,478
Previous 535,478
189.92%
Holding current value
$24.5 Million
Previous $7.8 Million
329.86%
% of portfolio
0.42%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding CELC
# of Institutions
82Shares Held
22.9MCall Options Held
24.9KPut Options Held
4K-
Perceptive Advisors LLC New York, NY2.36MShares$37.3 Million1.07% of portfolio
-
Morgan Stanley New York, NY2.35MShares$37.1 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT1.73MShares$27.4 Million3.06% of portfolio
-
Commodore Capital LP New York, NY1.56MShares$24.6 Million2.9% of portfolio
-
Eventide Asset Management, LLC Boston, MA1.39MShares$22 Million0.48% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $236M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...